Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and safety of tirzepatide, GLP‐1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta‐analysis
Xin‐Hui Pan, B.C. Tan, Yip Han Chin, et al.
Obesity (2024) Vol. 32, Iss. 5, pp. 840-856
Closed Access | Times Cited: 20

Showing 20 citing articles:

Global burden of cardiovascular diseases: projections from 2025 to 2050
Bryan Chong, Jayanth Jayabaskaran, Silingga Metta Jauhari, et al.
European Journal of Preventive Cardiology (2024)
Closed Access | Times Cited: 46
Comparative efficacy of incretin drugs on glycemic control, body weight, and blood pressure in adults with overweight or obesity and with/without type 2 diabetes: a systematic review and network meta-analysis
Song Liu, Jiaqiang Hu, Chen Zhao, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access | Times Cited: 2
The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions
Rachel Sze Jen Goh, Bryan Chong, Jayanth Jayabaskaran, et al.
The Lancet Regional Health - Western Pacific (2024) Vol. 49, pp. 101138-101138
Open Access | Times Cited: 11
Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach
Nicholas Chew, Anurag Mehta, Rachel Sze Jen Goh, et al.
Circulation (2024) Vol. 151, Iss. 1, pp. 98-119
Closed Access | Times Cited: 10
Nutritional Challenges and Treatment After Bariatric Surgery
Violeta Moizé, Blandine Laferrère, Sue A. Shapses
Annual Review of Nutrition (2024) Vol. 44, Iss. 1, pp. 289-312
Closed Access | Times Cited: 6
Therapeutic Advances in Obesity: How Real-World Evidence Impacts Affordability Beyond Standard of Care
Dimitrios Patoulias, Theocharis Koufakis, Ieva Ruža, et al.
Pragmatic and Observational Research (2024) Vol. Volume 15, pp. 139-149
Open Access | Times Cited: 6
The prognostic value of metabolic dysfunction‐associated steatotic liver disease in acute myocardial infarction: A propensity score‐matched analysis
Gwyneth Kong, Grace Cao, Jaycie Koh, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 8, pp. 3328-3338
Closed Access | Times Cited: 5
Estimating Cardiovascular Benefits of Tirzepatide in Sleep Apnea and Obesity: Insight from the SURMOUNT-OSA Trials
Guglielmo Beccuti, Fabio Bioletto, Mirko Parasiliti‐Caprino, et al.
Current Obesity Reports (2024) Vol. 13, Iss. 4, pp. 739-742
Open Access | Times Cited: 5
GLP-1-based therapies for the treatment of resistant hypertension in individuals with overweight or obesity: a review
Candace Jarade, Tetiana Zolotarova, Areesha Moiz, et al.
EClinicalMedicine (2024) Vol. 75, pp. 102789-102789
Open Access | Times Cited: 4
The Effects of Glucagon‐Like Peptide‐1 Receptor Agonists on Mitochondrial Function Within Skeletal Muscle: A Systematic Review
Victoria J. Old, Melanie J. Davies, Dimitris Papamargaritis, et al.
Journal of Cachexia Sarcopenia and Muscle (2025) Vol. 16, Iss. 1
Open Access
CSN-CRL Complexes: New Regulators of Adipogenesis
Dawadschargal Dubiel, Michael Naumann, Wolfgang Dubiel
Biomolecules (2025) Vol. 15, Iss. 3, pp. 372-372
Open Access
Comparing clinical outcomes of adults with obesity receiving tirzepatide versus bariatric metabolic surgery: A multi‐institutional propensity score‐matched study
Jheng‐Yan Wu, S.C Chan, Wan‐Hsuan Hsu, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Current and Emerging Parenteral and Peroral Medications for Weight Loss: A Narrative Review
Abdullah Al Lawati, Ayman Alhabsi, R. Rahul, et al.
Diseases (2025) Vol. 13, Iss. 5, pp. 129-129
Open Access
Tirzepatide as an innovative treatment strategy in a pre-clinical model of obesity-driven endometrial cancer
Weimin Kong, Boer Deng, Xiaochang Shen, et al.
Gynecologic Oncology (2024) Vol. 191, pp. 116-123
Open Access | Times Cited: 3
Efficacy and Safety of Tirzepatide for Weight Management in Non-Diabetic Obese Individuals: A Narrative Review
Mohammed Sallam, Johan Snygg, Sara El Ghandour, et al.
Obesities (2025) Vol. 5, Iss. 2, pp. 26-26
Open Access
Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events
Long He, Qiuyu Li, Yongfeng Yang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Targeted deletion of Fibroblast Growth Factor-23 rescues metabolic dysregulation of diet-induced obesity in female mice
Min Young Park, Chia‐Ling Tu, Luce Pèrié, et al.
Endocrinology (2024) Vol. 165, Iss. 12
Open Access | Times Cited: 2
Response to review by Pan et al.
Ulf Holmbäck
Obesity (2024) Vol. 32, Iss. 9, pp. 1603-1604
Closed Access
Old and new anti-obesity drugs
Salimeh Dodangeh, Shirin Hasani‐Ranjbar
Journal of Diabetes & Metabolic Disorders (2024) Vol. 24, Iss. 1
Closed Access
Long‐term all‐cause mortality of metabolic‐dysfunction associated steatotic liver disease based on body weight phenotypes following acute myocardial infarction: A retrospective cohort study
Jaycie Koh, Ayman Mohamed, Gwyneth Kong, et al.
Diabetes Obesity and Metabolism (2024) Vol. 27, Iss. 2, pp. 683-696
Closed Access
Page 1

Scroll to top